期刊文献+

致密细斑点型抗核抗体及其特异性自身抗体在自身免疫病的临床意义

Clinical significance of dense fine speckled antinuclear antibody and its specific autoantibody in autoimmune disease
下载PDF
导出
摘要 自身免疫病(autoimmune disease,AID)是由机体免疫系统受环境或遗传等因素作用产生针对自身成分的自身抗体和(或)致敏T淋巴细胞,导致机体组织器官损伤或功能障碍的疾病。当前,临床上诊断AID主要基于患者的临床表现和实验室指标,而AID常伴有特征性自身抗体。自身抗体检测已被广泛应用于临床实验室,致密细斑点型(dense fine speckled,DFS)ANA是近年来受到重视且被列为ANA检测必报的荧光模型。致密细斑点型ANA及其特异性自身抗体(抗DFS70抗体)在AID中的临床相关性尚有初步研究,但并不明确。本文就致密细斑点型ANA及抗DFS70抗体在AID中的临床相关性、各种免疫学检测方法的临床应用价值及其临床检测策略进行综述,为临床诊断AID提供新思路。 Autoimmune disease(AID)is a disease that the immune system produces autoantibodies or sensitized T lymphocytes against its own components which are affected by environmental or genetic factors,resulting in tissues and organs damage or body s dysfunction.At present,the diagnosis of AID is mainly based on the patient s clinical manifestations and laboratory autoantibody testing,because AIDS is always accompanied by specific anti-nuclear antibody(ANA)fluorescence patterns and characteristic autoantibodies.Autoantibody detection has been widely used in clinical laboratories,the dense fine speckled(DFS)pattern is one of the ANA fluorescent patterns that has received attention in recent years and is listed as a mandatory report for ANA detection.There were some preliminary studies of DFS ANA and its specific autoantibodies(anti-DFS70 antibodies)in AIDThis review discusses the clinical relevance of the dense fine speckled ANA and the anti-DFS70 antibodies in AID and the clinical application value of various immunoassay methods and their clinical detection strategies,aiming to provide new ideas for clinical diagnosis of AID.
作者 陈彬萱 马丽莎 周仁芳 CHEN Bin-xuan;MA Li-sha;ZHOU Ren-fang(Department of Laboratory Medicine,Affiliated Wenling Hospital,Wenzhou Medical University,Taizhou 317500,Zhejiang,China)
出处 《中华临床免疫和变态反应杂志》 CAS 2022年第3期292-299,共8页 Chinese Journal of Allergy & Clinical Immunology
基金 浙江省医药卫生科技计划项目(2022KY1413,2020RC148)。
关键词 自身免疫病 致密细斑点型 抗DFS70抗体 autoimmune diseases dense fine speckled pattern anti-DFS70 antibody
  • 相关文献

参考文献3

二级参考文献43

  • 1Guyatt GH, Oxman AD, Vist GE, et ah GRADE: an emerging consensus on rating quality of evidence and strength of recom- mendations[J]. BMJ, 2008, 336: 924-926.
  • 2Damoiseaux JG, Tervaert JW. From ANA to ENA: how to proceed?[J]. Autoimmun Rev, 2006, 5: 10-17.
  • 3Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982, 25: 1271-1277.
  • 4Linnik MD, Hu JZ, Heilbrunn KR, et al. Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus[J]. Arthritis Rheum, 2005, 52: 1129-1137.
  • 5Gomez-Puerta JA, Burlingame RW, Cervera R. Anti-chromatin (anti-nucleosome) antibodies[J]. Lupus, 2006, 15: 408-411.
  • 6Akhter E, Burlingame RW, Seaman AL, et al. Anti-Clq anti-bodies have higher correlation with flares of lupus nephritis than other serum markers[J]. Lupus, 2011, 20: 1267-1274.
  • 7Mok CC, Tang SS, To CH, et al. thromboembolism in systemic lupus of three ethnic groups[J]. Arthritis 2782. Incidence and risk factors of erythematosus: a comparison Rheum, 2005, 52: 2774-.
  • 8Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic anti- bodies[J]. Lancet, 2006, 368: 404-418.
  • 9Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative[J]. Arthritis Rheum, 2010, 62: 2569-2581.
  • 10Van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibod- ies: the past, the present and the future[J]. Nat Rev Rheumatol, 2011, 7: 391-398.

共引文献120

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部